Maximo F. Nougues

Chief Financial OfficeratPuma Biotechnology· In proxies 2021–2025

Pay in FY2025-12% from the year before · Puma Biotechnology stock +95.1% the same year

Maximo F. Nougues was paid $1.2M in FY2025 (Dec), down 12%. Puma Biotechnology stock rose 95.1% that year.

Pay$100 in the stock at the end of FY20 → $58

Pay is from the Summary Compensation Table of each Puma Biotechnology proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

PBYI
Puma BiotechnologyPublic company · 5 yr
- Chief Financial Officer2021 – Present · 5 yrStock in role -7%

Roles come from the proxy statements of each company.

Activity

Pay
Puma Biotechnology CFO pay fell 12% to $1.2M. The stock rose 95% in FY2025 (Dec).
DEF 14AApr 28, 2026
Pay
Puma Biotechnology CFO pay rose 14% to $1.4M. The stock fell 30% in FY2024 (Dec).
DEF 14AApr 28, 2025
Pay
Puma Biotechnology CFO pay rose 15% to $1.2M. The stock rose 2% in FY2023 (Dec).
DEF 14AApr 26, 2024
Pay
Puma Biotechnology CFO pay fell 45% to $1.1M. The stock rose 39% in FY2022 (Dec).
DEF 14AApr 26, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?